Evidence map›Paper›PMID 21325494›Full record

ArticleAmerican journal of physiology. Renal physiology2011

Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking.

Chunling Li, Weidong Wang, Christopher J Rivard, Miguel A Lanaspa, Sandra Summer, Robert W Schrier

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. TNF inhibits AQP2 expression via a miR137-dependent pathway.American journal of physiology. Renal physiology · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. (Pro)renin receptor in the kidney: function and significance.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Review
  10. Osmotic Adaptation by NaBiomedicines · 2020
    Review
  11. Aquaporin-3 in the epidermis: more than skin deep.American journal of physiology. Cell physiology · 2020
    Review
  12. Article
  13. Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.Annual review of pharmacology and toxicology · 2020
    Review
  14. The (pro)renin receptor in health and disease.Nature reviews. Nephrology · 2019
    Review
  15. Article
  16. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chunling LiDepartment of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA.
Weidong Wang
Christopher J Rivard
Miguel A Lanaspa
Sandra Summer
Robert W Schrier
University of Colorado Health · US

Funding

VASOPRESSIN SIGNAL TRANSDUCTION IN SMALL CELL LUNG CANCERP01DK019928 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI SCHRIER, ROBERT W · 1986 to 2008
$11.8M
NIDDK NIH HHS DK-19928
6 · The paper itself

Abstract

ANG II plays a major role in renal water and sodium regulation. In the immortalized mouse renal collecting duct principal cells (mpkCCD(cl4)) cell line, we treated cells with ANG II and examined aquaporin-2 (AQP2) protein expression, trafficking, and mRNA levels, by immunoblotting, immunofluorescence, and RT-PCR. After 24-h incubation, ANG II-induced AQP2 protein expression was observed at the concentration of 10(-10) M and increased in a dose-dependent manner. ANG II (10(-7) M) increased AQP2 protein expression and mRNA levels at 0.5, 1, 2, 6, and 24 h. Immunofluorescence studies showed that ANG II increased the apical membrane targeting of AQP2 from 30 min to 6 h. Next, the signaling pathways underlying the ANG II-induced AQP2 expression were investigated. The PKC inhibitor Ro 31-8220 (5 × 10(-6) M) and the PKA inhibitor H89 (10(-5) M) blocked ANG II-induced AQP2 expression, respectively. Calmodulin inhibitor W-7 markedly reduced ANG II- and/or dDAVP-stimulated AQP2 expression. ANG II (10(-9) M) and/or dDAVP (10(-10) M) stimulated AQP2 protein levels and cAMP accumulation, which was completely blocked by pretreatment with the vasopressin V2 receptor (V2R) antagonist SR121463B (10(-8) M). Pretreatment with the angiotensin AT(1) receptor (AT1R) antagonist losartan (3 × 10(-6) M) blocked ANG II (10(-9) M)-stimulated AQP2 protein expression and cAMP accumulation, and partially blocked dDAVP (10(-10) M)- and dDAVP+ANG II-induced AQP2 protein expression and cAMP accumulation. In conclusion, ANG II regulates AQP2 protein, trafficking, and gene expression in renal collecting duct principal cells. ANG II-induced AQP2 expression involves cAMP, PKC, PKA, and calmodulin signaling pathways via V2 and AT(1) receptors.

Indexed as

Analysis of VarianceAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsAquaporin 2Blotting, WesternCalmodulinCell LineCyclic AMPCyclic AMP-Dependent Protein KinasesDeamino Arginine VasopressinFluorescent Antibody TechniqueHormone AntagonistsKidney Tubules, CollectingMiceProtein Kinase CAngiotensin IIAngiotensin II Type 1 Receptor BlockersAqp2 protein, mouseAquaporin 2CalmodulinCyclic AMPCyclic AMP-Dependent Protein KinasesDeamino Arginine VasopressinHormone AntagonistsProtein Kinase CProtein Kinase InhibitorsReceptor, Angiotensin, Type 1Receptors, VasopressinRNA, Messenger

Identifiers

PMID21325494
PMCPMC3094043
OpenAlexW1964959104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.